MNKD FY 2024 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$286M+43.5% YoY

Gross Profit

$209M73.2% margin

Operating Income

$73M25.4% margin

Net Income

$28M9.7% margin

EPS (Diluted)

$0.10

Cash Flow

Operating Cash Flow

$43M

Free Cash Flow

$33M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$394M

Total Liabilities

$473M

Stockholders' Equity

-$79M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$286M	$199M	+43.5%
Gross Profit	$209M	$136M	+53.4%
Operating Income	$73M	$9M	+736.4%
Net Income	$28M	-$12M	+331.1%